Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorkell Andresson

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|January 22, 2008
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophyJohn Thurmond, Matthew E R Butchbach, Marty Palomo, et al.
Nature Immunology|June 1, 2023
HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responsesZhansong Lin, Arman A Bashirova, Mathias Viard, et al.
Cancer Research Communications|February 18, 2026
3D "emboli" culture models epithelial breast cancer cell oxidative mitochondrial metabolism with relevance for lung metastasisKuppusamy Balamurugan, Melissa R Mikolaj, Jonathan M Weiss, et al.
Molecular Cell|June 25, 2024
Genome-scale exon perturbation screens uncover exons critical for cell fitnessMei-Sheng Xiao, Arun Prasath Damodaran, Bandana Kumari, et al.
Nature Communications|January 28, 2021
IDH1 mutations induce organelle defects via dysregulated phospholipidsAdrian Lita, Artem Pliss, Andrey Kuzmin, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Molecular Cancer Therapeutics|July 13, 2026
Targeting mitochondrial protease in diffuse gliomasOlga Kim, Jinkyu Jung, Shaunak Sathe, et al.
Acta Neuropathologica Communications|September 10, 2024
A patient-derived cell model for malignant transformation in IDH-mutant gliomaOlga Kim, Zach Sergi, Guangyang Yu, et al.
Plos One|November 22, 2013
BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membraneJude Alsarraj, Farhoud Faraji, Thomas R Geiger, et al.
Cancer Discovery|January 26, 2021
TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through MerlinPedro Torres-Ayuso, Elvira An, Katherine M Nyswaner, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|January 22, 2008
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophyJohn Thurmond, Matthew E R Butchbach, Marty Palomo, et al.
Nature Immunology|June 1, 2023
HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responsesZhansong Lin, Arman A Bashirova, Mathias Viard, et al.
Cancer Research Communications|February 18, 2026
3D "emboli" culture models epithelial breast cancer cell oxidative mitochondrial metabolism with relevance for lung metastasisKuppusamy Balamurugan, Melissa R Mikolaj, Jonathan M Weiss, et al.
Molecular Cell|June 25, 2024
Genome-scale exon perturbation screens uncover exons critical for cell fitnessMei-Sheng Xiao, Arun Prasath Damodaran, Bandana Kumari, et al.
Nature Communications|January 28, 2021
IDH1 mutations induce organelle defects via dysregulated phospholipidsAdrian Lita, Artem Pliss, Andrey Kuzmin, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Molecular Cancer Therapeutics|July 13, 2026
Targeting mitochondrial protease in diffuse gliomasOlga Kim, Jinkyu Jung, Shaunak Sathe, et al.
Acta Neuropathologica Communications|September 10, 2024
A patient-derived cell model for malignant transformation in IDH-mutant gliomaOlga Kim, Zach Sergi, Guangyang Yu, et al.
Plos One|November 22, 2013
BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membraneJude Alsarraj, Farhoud Faraji, Thomas R Geiger, et al.
Cancer Discovery|January 26, 2021
TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through MerlinPedro Torres-Ayuso, Elvira An, Katherine M Nyswaner, et al.
Pageof 12